VolitionRx raises up to $1.9M in registered direct offering with warrants for additional $2.7M

VOLITIONRX LTD

Offering includes 445,648 Insider Shares at $0.5722 and 2,857,389 shares with warrants at $0.5722.
Form A warrants exercisable at $0.5722/share, Form B at $0.71525/share, both expire Dec 2029.
Gross proceeds upfront ~$1.9M; potential additional $2.7M if warrants fully exercised.
Proceeds for R&D, clinical studies, product commercialization, and working capital.
Insiders participate; no placement agent; closing expected on Dec 9, 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.